Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
about
Ursodeoxycholic acid for the prevention of colorectal adenomas and carcinomasSulindac suppresses beta-catenin expression in human cancer cellsBarrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisAkt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extractBiomarkers in phase I-II chemoprevention trials: lessons from the NCI experienceMolecular cancer prevention: Current status and future directionsExemestane for breast cancer prevention: a critical shift?Interaction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck CancersConvergence of nanotechnology and cancer prevention: are we there yet?Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionChemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancerPostal survey of physicians and laboratories: practices and perceptions of molecular oncology testingRegulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinicDiabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell linesEffective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the diseaseEndoscopy, morphology, morphometry and molecular markers: predicting cancer risk in colorectal adenoma.Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independenceEvaluation of the Effects of Airborne Particulate Matter on Bone Marrow-Mesenchymal Stem Cells (BM-MSCs): Cellular, Molecular and Systems Biological ApproachesA health services research agenda for cellular, molecular and genomic technologies in cancer care.Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathwaysEarly detection of and screening for colorectal neoplasiaTargeting the epidermal growth factor receptor for head and neck cancer chemopreventionCombination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis.Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.Trials and tribulations of interrogating biomarkers to define efficacy of cancer risk reductive interventionsKey tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.Phase II cancer prevention clinical trialsCold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.DNA repair and personalized breast cancer therapyDietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia.Salvianolic Acid B, a potential chemopreventive agent, for head and neck squamous cell cancer.Black raspberries inhibit intestinal tumorigenesis in apc1638+/- and Muc2-/- mouse models of colorectal cancerJNK1 is required for sulindac-mediated inhibition of cell proliferation and induction of apoptosis in vitro and in vivoThe gap junction as a "Biological Rosetta Stone": implications of evolution, stem cells to homeostatic regulation of health and disease in the Barker hypothesis.Chemopreventive properties of pinoresinol-rich olive oil involve a selective activation of the ATM-p53 cascade in colon cancer cell lines.Phase 0 trials: expediting the development of chemoprevention agents.5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model.
P2860
Q24241795-B1DACA00-ADED-40DA-A8FD-41548ADC8592Q24316103-1F6A331F-C90E-4B5F-B549-C0DE093F40EFQ24602426-DACA9FBD-BC3D-422D-AB73-CAA015E6E58EQ24680138-FE7F879B-ED47-4E04-A422-E969111AA40DQ26774585-DB13F2CA-E220-4E5B-9A7D-2DDECC6E8300Q26797207-5E518377-7C46-4A94-AD7C-1B647FB3234FQ27028211-09929FC7-386E-4A6A-9F34-A5939E1D0F12Q27495979-ACB53DF1-8743-484A-9D5E-C334F79E7F05Q28386699-DE9EE7D7-5667-4852-B454-720634B63F24Q28388335-24C82F9C-67C7-48D8-B6B6-A84E75FA76FAQ28388931-B1163F0C-F63A-4DCA-807E-E2E18AF69D91Q28680653-758F8145-7033-47D9-A39A-223EA10EF780Q30227715-18146C7B-DBDA-4746-B454-C22F564952E4Q30498812-F8507A0E-944F-4E44-94FA-AA6847F89D9EQ33384571-B1F09EDF-64C0-4282-838E-CC72707B8F66Q33416685-39448FB0-F791-4CB1-BA20-1318A046085DQ33419668-AAEF11B6-9754-442C-97AB-3BAFC2B2E9FFQ33579568-7A9DFA05-F190-451F-AC36-04D7F6A9B40CQ33616441-E8423640-4153-405B-BD71-D9A69518F9C3Q33749983-0AD0CA74-39E2-4A67-9658-733782659582Q33769748-78B18D48-90B4-4AC1-B406-49D620E53D39Q33781587-EA6EE770-0367-4235-90BC-5AEDCE071726Q33875694-D20EC12A-BA12-4BD4-9DF9-F3B49E45DF71Q33895607-5C5E2A57-B7B1-4204-B49B-5FBF6DD821F8Q33976435-0D1DF56D-3FBD-40C8-B31A-6AD5CFCDDD7EQ34008178-287E6EDE-C89F-40AC-899A-98B2A480AEEDQ34072742-9D9C153C-7C44-4FA6-9019-3E93A485D630Q34084254-24B73514-A8D1-412A-9A0E-6222B56D5679Q34112511-1122B5AE-6199-47D0-B1C2-0070CCF0D45BQ34121818-44B4E5D4-B625-460B-9581-F0D2044F4981Q34234936-31FF70F7-75C7-443C-8F2C-3CBBEFE7294AQ34285688-720F5A74-2D8E-4020-B378-252EEAC42860Q34442838-86C91D52-93F2-4B8C-9219-2779965E2583Q34481407-E2028EAC-9A3D-47BE-B0F0-D0CA833E83B4Q34575202-20EC1988-EE58-4F95-B880-E8963384D19FQ34678350-B06721D6-D9A2-413D-BCFD-B1EA6DB794F3Q34713267-62AD63AA-44E9-4C16-B5C6-D527018A8775Q34802510-D35BA7DB-1134-4373-8F1D-DC83F6904212Q34887797-1E4D73B5-DF8F-4839-985D-59F5689479B7Q34985378-C9886F7F-90A6-4EB7-BDEC-C9190DAE9930
P2860
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@ast
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@en
type
label
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@ast
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@en
prefLabel
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@ast
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@en
P2093
P50
P1476
Progress in chemoprevention dr ...... ancer--a plan to move forward.
@en
P2093
AACR Task Force on Cancer Prevention
Alison A Evans
Andrew J Dannenberg
Bernard Levin
Bharat B Aggarwal
Brian J Reid
Carlo C Maley
Caroline C Sigman
Dong M Shin
P304
P356
10.1158/1078-0432.CCR-06-1104
P407
P577
2006-06-01T00:00:00Z